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A B S T R A C T
Reuse of electrophysiology catheters and pacemaker devices has been practiced safely 
in several countries with significant cost-savings. Data from the literature evaluating 
clinical end-points, device-related complications, such as infections, and mechanical 
performance, suggest that this is a safe practice with no increased risk of complica-
tions or mortality. However, there remain practical, legal and ethical concerns which 
need to be addressed before a more widespread use of such practice is adopted. Also, 
protocols for validation of cleaning and sterilization, and estimations of the potential 
risks of infective agent transmission need to be more rigorous.
I N T R O D U C T I O N
The use of electrophysiological procedures has increased tremendously during the 
past 2 decades. Data from the world survey of cardiac pacemakers and implantable 
cardioverter defibrillators (ICD) show that new device implants show a steady increase 
from 1997 to 2001.1 This increase is much more pronounced with regard to new ICD 
implantations and implies a corresponding increase in electrophysiological studies.
Reuse of medical devices has long background, dating back to the 1970’s.2-4 Such 
practice has declined during the past several years, due to the increasing alertness 
for the possibility of transmission of infectious diseases, such as hepatitis B, human 
immunodeficiency virus (HIV) and Creuzfeldt-Jacobs disease. However, due to the 
realization that the health resources are finite, the issue of reusing medical devices 
remains important. This review will summarize an up-date on the subject.
R e f U R B I S h m e N T  O f  C A T h e T e R S  w I T h  A  l U m e N  
A N D  l U m e N - l e S S  e l e C T R O D e S
For many years, many institutions have routinely resterilized and reused catheters 
used in the catheterization laboratory. The catheters that can be resterilized and 
reused can be divided into two broad categories: (a) catheters with a lumen and (b) 
lumen-less catheters. The former include catheters used for right heart catheterization, 
diagnostic coronary angiography and interventional angioplasty procedures. With the 
current cleaning and sterilization techniques, these catheters are very difficult to be 
properly and adequately cleaned and, thus, refurbishment of these materials should not 
be practiced.4 This review will focus on reuse of lumen-less catheters, i.e. diagnostic 
electrophysiology catheters and ablation electrophysiology electrode-catheters.5-8
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Review of the history of national control on reuse  
in Europe and USA
Various European countries have practiced different ap-
proaches. In Finland, under the Hospital Supplies Act of April 
1985, industrially sterilized medical devices were labeled as 
ÇsterileÈ and as Çuse once onlyÈ. In France, the Ministry 
of Health took a clear policy for Çno reuseÈ of sterile devices 
and a circular to this effect was issued in December 1994. In 
contrast, Sweden adopted a policy favoring reuse. An inter-
mediate position was taken by the German and British Health 
authorities. In Germany, the German drug laws regulated ster-
ile medical devices and the German Pharmacopoeia contained 
monographs on sterilization methods and sterility testing. The 
British Ministry of Health issued a ÇDevices BulletinÈ about 
reprocessing and reuse of single-use devices, drawing attention 
to the possible hazards and indicating that the liability of such 
practice falls on the hospital concerned.
In June 1998 the European Commission has issued a 
“Medical Devices Directive-MMD”, which is mandatory in its 
application to all medical devices in the European Union mar-
ket. The Directive does not address the question of whether 
products should be for single use, reusable or reprocessable, 
but leaves the responsibility with the manufacturer to deter-
mine this and to label the products accordingly. The MDD 
states that the label must bear the following particulars: (a) the 
word “sterile” where appropriate, and (b) the indication “for 
single use only” where appropriate. If the device is reusable, 
information on the appropriate process to allow reuse, includ-
ing cleaning, disinfection, packaging and, where appropriate, 
the method of sterilization and any restriction on the number 
of uses. Therefore, if a device is labeled as “sterile” and “single 
use only”, the manufacturer is responsible for the integrity 
of that device for the first use only. If an institution reuses 
that device in a way not in accordance with the labeling and 
instructions for use (if any), then the institution is substituting 
itself for the manufacturer and should comply with the MDD. 
The hospital and/or the physician would be liable for all and 
any consequences arising from such misuse. However, since 
the manufacturers have financial conflicts, allocating the 
responsibilities of device reuse to the industry, clearly does 
not address the problem as a whole.
What happens on the other side of the Atlantic? A survey 
of 12 major medical centers in the United States in 1988 found 
that 9 of 12 centers reused diagnostic electrophysiology cath-
eters.2 With increasing cost constrains, it is likely that many 
more laboratories in the US have considered reuse.
The current regulations in the USA are in effect from 
November 11, 1977 and are described in the Compliance 
Policy Guide (CPG).9 This CPG states that hospitals that 
reprocess devices that are intended for single use assume full 
liability and responsibility for their reprocessing actions and 
should ensure that the products are adequately cleaned and 
sterilized, and that device safety, effectiveness and quality are 
maintained. On May 5-6, 1999, the FDA and the Association 
for the Advancement of Medical Instrumentation (AAMI) 
cosponsored a conference at Crystal City, Virginia on the 
practice of reprocessing and reusing medical devices. After 
that meeting, the FDA made a commitment to reevaluate its 
position on the reuse of medical devises. The FDA’s strategy 
will emerge, among others, from (a) information provided by 
the device manufacturers on risks associated with reuse of 
their devices, (b) exploration of recognized consensus stand-
ards that can be applied to reprocessing devices intended for 
single use (e.g. will verify and validate cleaning, disinfection 
and/or sterilization of devices), as well as from the exploration 
of the development of additional consensus standards to ad-
dress the safety, effectiveness and performance of reprocessed 
devices. The FDA will consider developing a research program 
on reuse of medical devices and explore avenues to publish and 
disseminate research and other information on reuse.
R e q U I R e m e N T S  O f  e l e C T R O D e - C A T h e T e R 
R e U S e
An electrode-catheter must fulfill the following require-
ments, in order to be safely reused:
 1. It must be sterile.
 2) It must be free of any remnants of cleaning materials, since 
these materials can be pyrogens or may cause hemolysis.
 3) The material must be intact.
 4) The catheter must maintain its original functional capac-
ity.
R I S K  O f  I N f e C T I O N
The risk of infection is probably of the greatest general 
concern. In a study of reused electrode catheters (USCI), 
surveillance cultures performed on 58 reused catheters failed 
to show any bacterial growth and biological indicators revealed 
adequate sterilization procedures.10 In the 1988 USA survey,2 
the prevalence of bacteremia was 0.03% in the single use group 
and 0.018% in the reuse group; the prevalence of superficial 
skin infections at the site of catheter insertion was 0.03% in 
the single use group versus 0.002% in the reuse group. None 
of these differences were statistically different. It can be con-
cluded that electrode catheters can be made safe for reuse 
with current cleaning and disinfecting methods.
f U N C T I O N A l  I N T e g R I T y
Dunnigan et al10 studied diagnostic electrode-catheters 
used an average of 8 times. The testing protocol included (a) 
visual inspection for cracks and bends (b) manual flexion and 
(c) impedance measurements. Of the 178 catheters studied, 
122 (68.5%) were deemed acceptable for reuse, while 32 were 
rejected due an insulation defect and 24 were rejected due to 
impedance increase.
Avitall et al11 investigated the reuse of ablation catheters 
without a thermistor, used an average of 5 times approxi-
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mately. Of the 69 ablation catheters examined, 33 (48%) were 
found flawless, while 17 were rejected because of insulation 
defect, 13 because of loss of deflection and 6 due to electrical 
discontinuation. Recently, a study from Sweden,12 tested the 
performance of ablation electrode catheters with a thermistor. 
Of the 74 catheters used an average of 7.6 times, 33 (44.5%) 
were found functionally intact, while 14 showed a thermistor 
defect, 17 were rejected because of loss of deflection and 7 
due to electrical discontinuation.
Thus, it appears that approximately 70% of diagnostic 
electrode catheters can be safely reused an average of 8 
times, while 40% to 50% of ablation catheters can be reused 
approximately 5 to 7 times.
C O S T  S Av I N g S
It is conceivable that the cost savings of reusing lumenless 
catheters in the electrophysiology laboratory are enormous. It 
is estimated that the cost of an electrophysiology diagnostic 
study can be reduced by approximately 85% and the cost of 
an ablation procedure by approximately 60%. This would be 
of particular benefit for countries with less economic capac-
ity, like Greece.
R e U S e  O f  l U m e N l e S S  C A T h e T e R S :  S U m m A R y
The reuse of diagnostic and ablation electrode catheters 
in the electrophysiology laboratory appears feasible and safe 
and significantly reduces the cost of a diagnostic electro-
physiology study or an ablation procedure. However, further 
clinical data are necessary. These data should address the 
effect of sterilization techniques on Creuzfeldt-Jacobs and 
other prion diseases. In addition, with the advent of newer 
ablation procedures, such as ablation of atrial fibrillation foci 
in the pulmonary veins, more ÇelegantÈ performance of the 
ablation electrode catheters may be expected. More data on 
these issues are awaited.
R e U S e  O f  PA C e m A K e R S
In many countries the reuse of pacemakers has been 
practiced for decades. Sweden has a long tradition of reusing 
pacemakers. By Swedish law, all implanted pacemakers and 
defibrillators must be explanted after death to avoid explosion 
of the device during cremation. Explantation of a pacemaker is 
not defined as an autopsy and can be performed by any physi-
cian or technician without permission from the patient’s rela-
tives. In other countries with a tradition of reusing pacemakers, 
such as Canada and the Netherlands, the patient must consent 
to donating his/her pacemaker for possible reuse. After death, 
consent for explantation must be given by the relatives.
When examining the issue of reusing pacemakers, one 
should provide answers to the following questions:
 1. Is it safe?
 2. Is it legal?
 3. Is it cost-effective?
 4. Is it accepted by the patients?
 5. Is it ethical?
S A f e T y  I S S U e S
Studies evaluating the safety of pacemaker reuse originate 
mainly from Sweden, from Canada and from the Netherlands. 
However, studies on this matter are also available from other 
countries, such as the USA, Italy and India. With the appropri-
ate selection protocol (i.e. implanting reused pacemakers only 
at the beginning of their battery life) and carefully selecting 
patients to receive a reused pacemaker (i.e. mostly elderly 
patients), the percentage of generator replacement rate does 
not appear significantly different, compared to implantations 
of a new unit.13,14
The results of seven studies comparing the complication 
rates (including infections and technical malfunctions) of 
reused pacemaker implants versus those of new units showed 
that the complication rates were comparable.
l e g A l  I S S U e S
To date, there is no unanimous legislation among the 
members of the European Union. The first legal issue that 
needs to be addressed is whose property is the pacemaker. 
In Sweden, the pacemaker is the property of the implanting 
center that originally bought it. The implanting center has 
the right to retrieve explanted pacemakers. In other countries 
reusing pacemakers, such as Canada and the Netherlands, 
the pacemaker, once implanted, is the property of the pa-
tient. Furthermore, written consent from the patient elected 
suitable for the implantation of a reused pacemaker must be 
obtained. In Sweden and Norway consent from the patient, 
who is a candidate to receive a reused unit, is not mandatory 
and this issue is currently under debate. Besides the need for 
a consent form, other legal issues, that need to be addressed, 
are (a) whether a new ÇCE markÈ is required for the reused 
pacemaker and (b) liability issues.
C O S T  S Av I N g S
Reusing pacemakers is anticipated to reduce costs signifi-
cantly. Taking into account that approximately 40% to 50% 
of new implants are dual-chamber pacemakers and taking a 
fairly conservative approach that only 20% of pacemakers are 
suitable for reuse, the estimated annual savings for Greece are 
at the range of 3.6 million Euros.
PA T I e N T  A C C e P T A N C e
Patient acceptance rates have not been extensively studied. 
Acceptance rates may vary in different countries, depending 
on cultural, religious and educational parameters. Studies in 
Canada15 and in the Netherlands16 indicate that a very high 
proportion of patients, at the range of 80% to 90%, consented 
to a reused pacemaker.
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e T h I C A l  I S S U e S
Ethics reflect the aspirations of a society emerging from a 
social consciousness and, as such, are bound to vary with time 
and place. With the development of society, older ethical con-
cepts are being challenged and newer concepts ensue. Medical 
and scientific advances on one hand and the constraining costs 
on the other, are raising new questions and dilemmas, to which 
there are as yet no clear answers.
Several independent parties, such as politicians, govern-
ment bureaucrats, hospital administrators, insurance compa-
nies are trying to “solve” the problem of cost-constraints, not 
always to the patients’ benefit. It is my view that the physician, 
who is the final link in the long chain of the health care system, 
should play an active role in the decision-making process. 
Reuse of medical devices represents a major challenge in 
this regard.17-19 There is much evidence to suggest that some 
medical devices, especially those used in the electrophysiology 
laboratory can be reused safely and that the risk is negligible. 
However, more evidence is needed. Of paramount importance 
is the fact that the reuse of devices can not only reduce costs 
significantly, but make therapies accessible to patients for 
whom these were not previously a possibility.
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